Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 12/20 | 0.51 |
| ▸ | NPY1R | P25929 | 7/20 | 0.51 |
| ▸ | NPY2R | P49146 | 5/20 | 0.51 |
| ▸ | NPY5R | Q15761 | 5/20 | 0.51 |
| ▸ | BACE1 | P56817 | 7/20 | 0.47 |
| ▸ | BACE2 | Q9Y5Z0 | 1/20 | 0.47 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.47 |
| ▸ | CTSD | P07339 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31344443 | 1.00 | NPY4R (0.51) | NPY4RNPY1RNPY2RNPY5RBACE1 | |
| SCHEMBL31344448 | 0.96 | NPY4R (0.49) | NPY4RNPY1RNPY2RNPY5RBACE1 | |
| SCHEMBL30933209 | 0.96 | NPY4R (0.51) | NPY4RNPY1RNPY2RNPY5RBACE1 | |
| SCHEMBL30531638 | 0.96 | NPY4R (0.51) | NPY4RNPY1RNPY2RNPY5RBACE1 | |
| SCHEMBL31674373 | 0.95 | NPY4R (0.44) | NPY4RNPY1RNPY2RNPY5RBACE1 | |
| SCHEMBL31605454 | 0.95 | NPY4R (0.48) | NPY4RNPY1RNPY2RNPY5RBACE1 | |
| SCHEMBL30531634 | 0.94 | NPY4R (0.56) | NPY4RNPY1RNPY2RNPY5RBACE1 | |
| SCHEMBL31344449 | 0.94 | NPY4R (0.52) | NPY4RNPY1RNPY2RNPY5RKEAP1 | |
| SCHEMBL31097750 | 0.94 | NPY4R (0.52) | NPY4RNPY1RNPY2RNPY5RKEAP1 | |
| SCHEMBL31752429 | 0.93 | NPY4R (0.57) | NPY4RNPY1RNPY2RNPY5RBACE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025027182-A1 | AGENTS AND METHODS FOR TARGETED DELIVERY TO CELLS | BioNTech SE (DE) | 2025-02-06 | — | — | WO | disclosed |